当前位置: X-MOL 学术Blood Cancer J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases.
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2022-07-06 , DOI: 10.1038/s41408-022-00696-4
Maymona G Abdelmagid 1 , Mark R Litzow 1 , Kristen B McCullough 1 , Naseema Gangat 1 , Animesh Pardanani 1 , Hemant S Murthy 2 , James M Foran 2 , Rhett P Ketterling 3 , David Viswanatha 3 , Kebede H Begna 1 , Ayalew Tefferi 1
Affiliation  



中文翻译:

具有唯一 P190 (e1a2) BCR::ABL1 的慢性期 CML:连续 10 例的长期结果。

更新日期:2022-07-06
down
wechat
bug